The adult liver is an organ without constitutive lymphoid components. Therefore, any intrahepatic T cell found in chronic hepatitis should have migrated to the liver after infection and inflammation. Because of the little information available on the differences between intrahepatic and peripheral T cells, we used recombinant proteins of the hepatitis C virus (HCV) to establish specific T cell lines and clones from liver biopsies of patients with chronic hepatitis C and compared them with those present in peripheral blood mononuclear cells (PBMC). We found that the protein nonstructural 4 (NS4) was able to stimulate CD4 + T cells isolated from liver biopsies, whereas with all the other HCV proteins we consistently failed to establish liver-derived T cell lines from 16 biopsies. We then compared NS4-specific T cell clones obtained on the same day from PBMC and liver of the same patient. We found that the 22 PBMC-derived T cell clones represent, at least, six distinct clonal populations that differ in major histocompatibility complex restriction and response to superantigens, whereas the 27 liver-derived T cell clones appear all identical, as further confirmed by cloning and sequencing of the T cell receptor (TCK) variable and hypervariable regions. Remarkably, none of the PBMC-derived clones has a TCK identical to the liver-derived clone, and even with polymerase chain reaction oligotyping we did not find the liver-derived clonotypic TCK transcript in the PBMC, indicating a preferential intrahepatic localization of these T cells. Functionally, the liver-derived T cells provided help for polyclonal immunoglobulin (Ig)A production by B cells in vitro that is 10-fold more effective than that provided by the PBMC-derived clones, whereas there is no difference in the help provided for IgM and IgG production. Altogether these results demonstrate that the protein Ng4 is highly immunogenic for intrahepatic CD4 + T cells primed by HCV in vivo, and that there can he compartmentalization of some NS4-specific CD4 + T cells to the liver of patients with chronic hepatitis C.
H
epatitis C virus (HCV) 1 is an KNA virus responsible for the majority of blood-borne non-A, non-B hepatitis (1) , which induces chronic hepatitis in at least half the infected patients (2) . At present, it is not known what role the immune response plays in the course of HCV infection. We have previously reported that PBMC from HCV-infected individuals proliferate in response to HCV recombinant proteins and that peripheral responses to the Core protein correlate with a benign course of infection (3) . However, the study 1 Abbreviations used in thispaper: E, envelope; HCV, hepatitis C virus; HS, human serum; NS, nonstructural; SE, staphylococcal enterotoxin; SOD, superoxide dismutase.
of T cell responses in the peripheral blood, although critical to the understanding of both the immunogenicity of viral proteins and the immune status of the individual, does not necessarily reflect the pattern of T cell responses present in the liver. Information on phenotype and function of intrahepatic T cells may be relevant to the understanding of the preferential presence, i.e., compartmentalization, of some T cells into the liver and can therefore help in elucidating the immunopathogenesis of chronic hepatitis C. Since the adult liver is an organ without constitutive lymphoid components (4) , any intrahepatic T cell found in chronic hepatitis should have migrated to the liver after infection and inflammation. Once in the tissue, T cells can be restimulated by Ag to un-dergo further clonal expansion and can exert their effector functions, whether they are cytotoxic or delayed-type hypersensitivity (DTH) responses. Generally, CD4 + T cells are critical to the accomplishment of any effector function of the immune system, since they can act both directly as DTH inducers (5) and may be killer cells (6) , and indirectly helping both B lymphocytes to produce neutralizing Ab (7) and CD8 + T cell precursors to mature to effector killer cells (8) .
We have studied the specificity and function of CD4 + T lymphocytes infiltrating the liver of patients with chronic hepatitis C. Using recombinant proteins of HCV, we established T cell lines and clones from both liver biopsies and, when possible, the corresponding PBMC. To study T cell compartmentalization, CD4 + T cell clones obtained from PBMC and liver of the same individual and specific for the same HCV protein were compared for MHC restriction, TCR reactivity to bacterial superantigens, lymphokine production, killing ability, and helper activity for Ig production by B cells in vitro. Here we show evidence that some nonstructural 4 (NS4)-specific CD4 + T cells, with a peculiar ability to help IgA production, can compartmentalize to the liver of patients with chronic hepatitis C.
Materials and Methods
Patients with Chronic Hepatitis C. The three patients studied had HCV-specific serum antibodies, detected by two second-generation ELISAs (Abbott Laboratories, North Chicago; and Ortho Diagnostic Systems, Raritan, NJ), specific for the Core, NS3, and NS4 proteins. Two patients (nos. 13 and 14) had ongoing chronic hepatitis demonstrated by elevated serum levels (>40 U/liter) of alanine aminotransferase (ALT) for >1 yr. No. 13 is a 61-yr-old female with a histologic diagnosis of chronic active hepatitis, and no. 14 is a 53-yr-old male with a histologic diagnosis of nonspecific reactive hepatitis. The third study subject is a patient (no. 71) whose chronic hepatitis C went into clinical remission upon IFN-c~ treatment, as demonstrated by the range values of serum ALT (i.e., 8-14 U/liter) in 12 monthly tests and by the absence of symptoms of liver disease for 12 mo since IFN-a treatment. No. 71 is a 36-yrold female with a histologic diagnosis of fibrosis.
HCV Recorabinant Proteins. The HCV proteins Core, envelope 1 (El), envelope 2 (E2), NS3--4, NS4, and NS5 were expressed as COOH-terminal fusions with human superoxide dismutase (SOD) in yeast ( Saccharomyces cerevisiae) using the method described earlier for the expression of the C100-3 HCV-Ag (1) and purified as previously reported (3) .
Cell Cultures. Culture medium was RPMI 1640 (Gibco Laboratories, Grand Island, NY) supplemented with 2 mM L-glutamine, 1% nonessential amino acids, I mM sodium pyruvate, 100 U/ml penicillin, 100/~g/ml streptomycin, and 5% human serum (KPMI-HS). For the growth of T cell lines and clones, RPMI-HS was supplemented with 50 U/ml rib2 (Cetus Corp., Emeryville, CA).
Establishment of Liver-derived T Cell Lines. Liver biopsies ('~2-cm length and 1.5-mm diameter), taken from patients who gave informed consent, were put in petri dishes with RPMI-HS and washed vigorously with a Pasteur pipette, to eliminate contaminating blood lymphocytes. They were manually homogenized in glass mortars (Bellco International, Feltham, UK) in the presence of 5 ml RPMI-HS, and mononuclear cells were separated by Ficoll-Hypaque (Pharmacia, Uppsah, Sweden) density-gradient centrifugation, washed twice in RPMI-HS, and counted. Generally, we recovered 3-8 x 104 mononuclear cells/biopsy. Approximately 6 x 103 liver-derived mononuclear cells were cultured with 103 irradiated (3,000 tad) autologous PBMC in 0.2 ml of RPMI-HS in 96-well flat-bottomed microplates in the presence of 9 #g/ml of recombinant HCV pro~dns. After 7 d, the growing cultures were supplemented with rlL-2 (50 U/ml) and, after an additional 15 d, they were tested in Ag-specific proliferation assays.
PBMC Proliferation Assay. Heparinized venous blood drawn from patients who gave informed consent was diluted (vol/vol) in PBS. PBMC were separated by Ficoll-Hypaque density-gradient centrifugation. For the proliferation assays, PBMC (2 x 103 cells) in 0.2 ml of RPMI-HS were cultured in 96-well flat-bottomed microplates in the presence or absence of HCV recombinant proteins at 1, 3, and 9 gg/ml final concentrations in triplicate wells. After 6 d I gCi of [3H]thymidine (sp act, 5 Ci/mmol; Amersham Corp., Amersham, UK) was added in each well and DNAincorporated radioactivity was measured after an additional 16 h by liquid scintillation counting. The SD was <40% in all cases. Proliferation was considered positive when stimulation index (cpm incorporated in response to antigen/cpm incorporated in the absence of antigen) was >--4.
Establishment of PBMC-derived T Cell Lines. PBMC (103) were cultured in 0.2 ml RPMI-HS in 96-well flat-bottomed microplates in the presence of 9 gg/ml of recombinant HCV proteins. After 7 d, rib2 (30 U/ml) was added and after an additional 15 d cultures were tested in Ag-specific proliferation assays.
T Cell Line Proliferation Assay. T cell lines (4 x 104 cells) were cultured with 103 irradiated (3,000 tad) autologous PBMC in 0.2 ml of RPMI-HS in 96-well flat-bottomed microplates in triplicate wells in the presence or absence of HCV recombinant proteins at 1, 3, and 9 gg/ml. After 2 d, 1 #Ci of [3H]thymidine/well was added and DNA-incorporated radioactivity was measured after an additional 16 h by liquid scintillation counting. The data are expressed as mean cpm + SD of triplicate wells.
Establishment of T Cell Clones. T cell clones were established as previously described (9) . Briefly, NS4-specific T cell lines, both from PBMC and liver, were cloned by limiting dilution (0.3 cell/well) in the presence of irradiated (3,000 rad) allogeneic PBMC (5 x 103/ml), PHA (1 gg/ml; Wellcome, Dartford, UK), and rlL-2 (100 U/ml) in 20-gl cultures in Terasaki trays. The T cell clones obtained were screened for their capacity to proliferate in response to the HCV protein used as stimulator. EBV-transformed B (EBV-B) cell lines were obtained as described (9) . HLA-DR homozygous EBV-B cell lines were obtained from the European Collection of Animal Cell Cultures (ECACC; Salisbury, UK).
Proliferation Assay of T Cell Clones. T cells (2 x 104) were cultured with irradiated (6,000 tad) EBV-B cells (1.5 x 104) in 0.2 ml RPMI-HS in 96-well flat-bottomed microphtes in triplicate wells in the presence or absence of 1, 3, and 9 gg/ml of the Ag. After 2 d, 1 gCi of [~H]thymidine was added and the radioactivity incorporated was measured after an additional 16 h by liquid scintillation counting. For the proliferative responses to superantigens, experiments were performed as above but antigens were substituted with 1 ng/ml of staphylococcal enterotoxin (SE) A, SEB, SEC1, SEC2, SEC3, SED, SEE, toxic shock syndrome toxin (TSST), and exfoliative toxin (ExT) (Toxin Technology Inc., Sarasota, FL).
Flow Cytoraetric Analysis. TCR Cloning and Sequencing. Total KNA was isolated from T cell clones according to Chomczynski and Sacchi (10) . cDNA synthesis and PCK were carried out as described by Uematsu (11) . Briefly, oligo(dT)-primed double-stranded cDNA was synthesized from 1 #g of total RNA using Moloney murine leukemia virus (M-MLV)-derived reverse transcriptase, RNase H, Escherichia coil DNA polymerase I, and E. coli DNA ligase, followed by incubation with T4 DNA polymerase for bhnt-end formation. The bluntended cDNA was circularized with T4 DNA ligase in a volume of 10 #1. The ligated material was used as template for the PCK. Amplifications of ot and/3 chains were performed separately in 50-/~l reaction mixtures containing primers either for Cot or for C/3 regions (each at 300 nM), 67 mM "Iris HC1, pH 8. for 60 s), the Klenow fragment of E. coil DNA polymerase I was added to ensure full-length DNA synthesis. PCR products were purified by phenol-chloroform extraction, precipitated with ethanol, and digested with restriction endonuclease in excess amounts of SalI and NotI. Fragments of the expected sizes for the cDNAs were separated by preparative agarose gel electrophoresis and purified by adsorption on glass beads. The material was ligated into pBluescript previously digested with SalI and NotI, and the obtained recombinants were used to transform XL1 blue E. coil cells.
The colonies obtained were screened using a colony hybridization technique and an internal Ca (TCTCTCAGCTGGTACACGGCA-GGGTCAGGG) or C/3 (GGACCTGAACAAGGTGTTCCCAC-CCGAGGT) 32p-labeled oligonucleotide as probe. Single plaques were picked and grown up, and recombinant phage DNA was purified for DNA sequence determination. Sequencing reactions were done using the Sequenase sequencing system (United States Biochem. Corp., Cleveland, OH).
TCR Transc@t Identification by PCR Oligotyping. PBMC (3 x
106) were stimulated with NS4 (5 #g/ml) in 15 replicate microcultures (2 x 103 cells/0.2 ml per well) in 96-well flat-bottomed microplates, grown to ",~4 x 106 cells, and five pools were made, each of calls from three wells. Each pool was processed as follows: total KNA was extracted and 0.5 #g of it was reverse transcribed. 5% of the cDNA was amplified in 50 #1, using 30 pmol of each primer. For the TCK fl chains amplification, the following primers were used: C/3 5'-GGTGTGGGAGAATTCTGCTTCTGA-Y and V/33 5'-CGCTIL-"I~CCGGATICTGGAGTCC-Y. The PCR reactions were heated once for 4 rain at 94~ followed by 20 s at 62~ 2 rain at 72~ and 1 min at 94~ for 35 cycles, followed by a 10-min extension at 72~ 10 #1 of each PCR reaction was fractionated on a 2% agarose gel, alkaly blotted onto N-Hybond nylon membrane, and hybridized overnight at 45~ with 3~P-labeled N region-specific oligonucleotide (5'-GCAGTCCCGGGGGGC-CCTATTCAC) in 6 x SSC, 6 x Denhardt's, and 0.2% SDS. The filters were washed twice in 6x SSC, 0.2% SDS at 45~ for 10 min, and twice at 65~ 2x SSC and 0.2% SDS. Optimal hybridization and washing temperatures were determined in cell mixing experiments in which the PCR oligotyping was performed on scaled numbers of the relevant clone mixed with a constant number of PBMC from unrelated donors. Assays for lg. IgM, IgG, and IgA in the culture supernatants
PCR-assisted
were measured with ELISA. Briefly, polystyrene microplates were coated with goat anti-human # or % or ot antiserum (10 #g/ml) in coating buffer (Na2CO3 0.18 g/liter, NaHCO3 2.1 g/liter, NaC1 9 g/liter, NaN3 0.2 g/liter), pH 8.6, at 4~ overnight. The plates were washed and appropriate dilutions of the culture supernatants in PBS-FCS were added for 2 h at room temperature. After washing, a goat anti-human # or 'y or ot antiserum, coupled to alkaline phosphatase, was added for a further 2 h. After a final wash, the enzyme bound to the wells was determined using 1 mg/ml p-nitrophenylphosphate (Sigma Chemical Co., St. Louis, MO) in 1 M ethanol amine buffer, pH 9.6. The absorbance at 405 nm was read with an automated photometer. The amount of Ig was determined by comparison with a standard curve constructed using known amounts of purified IgM, IgG, and IgA. Our ELISAs have the following sensitivity: IgM, 10-3,000 ng/ml; IgG, 1-500 ng/ml; IgA, 30-2,000 ng/ml.
Results

Liver-derived T Cell Lines Specific for HCV Proteins.
To assess the specificity of intrahepatic T cells primed by HCV infection in vivo, we studied, in patients with chronic hepatitis C, the response of liver-derived T cells to six HCV recombinant proteins corresponding to the putative Core, El, E2, and the nonstructural proteins NS3, NS4, and NS5 (13) .
The low number of T cells recovered from liver biopsies (3-8 x 104/specimen) did not allow direct proliferation experiments. Therefore, we tried to isolate liver-infiltrating T cells specific for HCV proteins by culturing low numbers (,05 x 103) of liver-derived mononuclear cells with recombinant HCV proteins in the presence of irradiated autologous PBMC. The growing cultures were then tested in Agspecific proliferation assays using autologous irradiated PBMC as APC.
We obtained, from three patients, specific T ceU lines from liver biopsies cultured with the protein NS4. Fig. 1 shows dose-response curves to NS4 of T cell lines from the patients nos. 13, 14, and 71. None of the lines responded to recombinant SOD expressed in yeast or to a crude yeast extract (data not shown), indicating that these T ceil lines were truly specific for NS4.
To determine the phenotype of T cells proliferating in response to NS4 in vitro, we determined by immunofluores- cence the phenotype of blast ceils present in the cell lines and compared it with the phenotype analyses performed on the fresh biotic material from the same patients. The mononudear cells isolated from the three biopsies were 50-75% TCR cr + , 15-35% CD4 + , and 20-50% CD8 + , whereas the blast cells present in the NS4-specific lines were >97% TCR o~/~ +, 80-90% CD4 +, and only 10-15% CD8 + (data not shown), indicating that only CD4 + T cells were stimulated by NS4.
With the other HCV proteins (Core, El, E2, and NS5) we failed to obtain Ag-specific T cell lines from any of the three liver samples. Furthermore, we consistently failed to obtain T cell lines specific for these antigens also with liver biopsies from 16 other patients with chronic hepatitis C. This is in contrast with what is found in PBMC, since we obtained T cell lines and clones specific for either Core, El, E2, or NS5 from PBMC of these patients (S. Abrignani, manuscript in preparation). We therefore conclude that NS4 is the only HCV Ag that allows growth in vitro of HCV-specific CD4 + T ceils from the liver.
Comparison of the NS4-specific CD4 + T Cells from Liver and PBMC.
To investigate functional and structural differences between local and peripheral T call response to NS4, we studied the PBMC of the three patients from whom we isolated liver-derived T cell lines specific for NS4. We first measured the proliferative response of their PBMC to the HCV proteins, and Fig. 2 shows that PBMC from patients nos. 13 and 14 did not respond to any HCV protein, while PBMC from no. 71 proliferated in response to E2, NS3, NS4, and NSS. We therefore established NS4-specific T cell lines from the PBMC of patient no. 71, which were collected on the same day when liver biopsy was taken. To have the widest spectrum of specific clones, the PBMC-derived lines were established starting from 106 mononudear calls. We then cloned by limiting dilution the NS4-specific T cell lines iso- Liver-derived T cell clones (n = 27) L4 (27) 68 2w15, 4w4 lated from both liver and PBMC of patient no. 71, and obtained 22 specific clones from the PBMC and 27 from the liver that proliferate in response to NS4 in the presence of irradiated autologous PBMC or EBV-B cells as APC. These clones do not recognize either recombinant SOD or a control yeast extract, and all are CD3 + , TCR o~//3 + , CD4 + , and CDS-(data not shown).
To investigate whether NS4-specific T cells present in the liver differed from those present in PBMC, the T cell clones were compared for MHC restriction and response to superantigens, which can indicate the type of VB genes used by T cells (14) . Table I shows, for all the clones, the proliferative response to NS4 presented by autologous EBV-B cells, the MHC restriction assessed with EBV-B cell lines homozygous for DR., and the proliferative response to various SEs. On the basis of the DR restriction and the response to toxins, we could identify six different groups of T cell clones specific for NS4 from the PBMC of patient no. 71. In contrast, all the liver-derived T cell clones appeared identical in DR` restriction and superantigen responses.
To investigate further the monodonality of liver T cells, we took randomly 4 of the 27 liver-derived T cell clones and sequenced their TCR o~ and B genes. Fig. 3 shows that they all use Vo~8.1 (15), Jc~25 (16), VB3.1 (17), JB1.6 (18) , and DB 1.1 (18) genes, and that the sequences of the N regions are identical in all four clones. This demonstrates that the four clones are identical and suggests that all the 27 liver clones derive from a single precursor.
Given the low number (1-2 x 103) of CD4 + T cells we used to establish liver cell lines, it is not very surprising that all the 27 liver-derived T cell clones are identical. However, it is remarkable that the pattern of toxin response (SEB and SED) found with the liver clones was not present in any blood-derived NS4-specific T cell clones. To investigate further the compartmentalization to the liver of this clone, and having the complete TCR c~ and 3 sequence of the liver T cell done, we attempted to detect the presence in the PBMC of the donotypic TCR transcripts using a PCR oligotyping technique that is very sensitive, allowing the detection of -10 cells among 106 irrelevant lymphocytes, and is highly specific. Therefore, 2 x 106 PBMC were stimulated with NS4 and expanded up to 4 x 10 6 cells. RNA was extracted, reverse transcribed, and amplified using V~ + C~/oligonucleotides; the amplified products were ffactionated on a gel, blotted, and hybridized with N region-specific oligonudeotides. amplified products of a control cell mixture containing 10 or 100 liver T cell dones and 106 irrelevant PBMC, whereas they do not hybridize to the amplified products from different pools of the PBMC no. 71. From all the above results we conclude that there is compartmentalization to the liver of a T cell clone that is either absent or present at a very low frequency in the PBMC.
Functional Differences between Liver-and Blood-derived T Cell Clones. We then asked whether there were functional differences between liver-and blood-derived T cells. For this, we studied the killing ability, the helper activity, and the lymphokine produced by the two sets of clones.
The killing ability of the clones was tested against autologous EBV-B cells incubated overnight with NS4 and then labeled with SlCr. We found that all the clones from both blood and liver were able to induce specific killing of 30-60% of the Ag-pulsed EBV-B cells (data not shown). We therefore conclude that the killing assay is not discriminating between liver-and PBMC-derived T cells.
The ability of T cells to help Ig production by B cells was assessed by coculturing activated and irradiated T cell clones with purified peripheral B cells for 10 d and then measuring IgM, IgG, and IgA in the culture supernatant. Table 2 shows that six PBMC-derived clones (each representing a distinct population) and two liver-derived T cell clones (which are identical) induce comparable amounts of IgM and IgG, but they differ in their ability to induce IgA production. Indeed, the liver-derived T cell clone induces levels of IgA produc- tion that are '~ 10-fold higher than those induced by PBMCderived T cell clones. We then asked whether this different help to B cells was due to differences in the type of lymphokines produced. We had quantitative assays available only for IL-2 (bio-assay on CTLL) and IFN-~/(ELISA), and for both lymphokines we did not find significant differences among blood and liver clones (data not shown). For other lymphokines, IL-2, -3, -4, -5, TNF-cz, -B, GM-CSF, TGF-B, and IFN-% we measured the mRNA with PCR. T cells were activated with antigen-pulsed B ceils, and after 12 h KNA was extracted and the presence of lymphokine mRNA assessed. A representative experiment in Fig. 5 shows that mKNA for all the lymphokines is present both in three PBMC-and in two liver-derived T cell clones. As a control, Fig. 5 shows that one representative blood T cell clone cultured with B cells without Ag has mKNA only for IL-3, GM-CSF, TGF-B, and TNF-/3. We therefore conclude that there are no qualitative differences in the type of lymphokines produced by blood-and liver-derived T cell clones specific for NS4, and that all the T cell clones analyzed are classifiable as Th0, the most common type of human T helper cells (19) .
Discussion
In the present study we addressed the issue of the local T cell responses into the liver of patients with chronic hepatitis C. We have found that the only HCV-specific T cell lines we could establish from liver biopsies were specific for NS4. This result strengthens our previous finding that NS4 is the most immunogenic HCV protein for peripheral CD4 + T cells (3) . Indeed, NS4 can be considered as an immunodominant region of HCV for liver-derived CD4 + T cells primed in vivo.
Although HCV particles have not yet been isolated, NS4 is considered a nonstructural protein of the virus (13) that should be in the infected cells but not in the virion particles. The high frequency of intrahepatic CD4 + T cells specific for NS4 could imply either a very effective charging of MHC class II molecules by peptides derived from endogenously syn- thesized NS4 (20) in infected hepatocytes that express MHC class II molecules during chronic hepatitis (21) , or that NS4 is a membrane protein, as suggested by its high hydrophobicity (13) , which recycles in the MHC class II pathway. Alternatively, it is possible that this protein is shed by infected cells, internalized by hepatocytes, macrophages, or specific B cells, and presented to CD4 + T cells. This last possibility would be consistent with the serology data demonstrating that NS4 (i.e., the C100-3 Ag) is a highly immunogenic protein also for antibody responses (1).
We failed to isolate, in 19 liver biopsies, T cells specific for HCV proteins other than NS4. This failure was not related to a defect of antigenicity of the proteins, since we obtained T cell lines and clones specific for either Core, El, E2, NS3, or NS5 from PBMC of these patients (S. Abrignani, manuscript in preparation). One obvious possibility is that specific T cells were not detected because in most livers they axe present at a frequency <1:1,000-2,000 CD4 + T cells, i.e., the number of liver CD4 + cells used for culturing with each single antigen. Alternatively, since proteins, such as E1 and E2, show considerable sequence heterogeneity among HCV isolates (22) , one could speculate that CD4 + T cells are present but recognize variable regions ofHCV proteim. Such T cells would not be stimulated by recombinant proteins from HCV isolates different from the patients' isohtes. Finally, we cannot rule out the possibility that these CD4 + T cells are present in the liver biopsies but are anergic or unresponsive to antigenic stimuli in vitro.
When we compared the NS4-specific responses in the liver and in the corresponding PBMC, we found a compartmentalization to the liver of patient no. 71. In this case, we obtained on the same day NS4-specific T cell lines both from PBMC and liver. These lines were cloned and PBMC-and liver-derived T cell clones specific for NS4 were compared for MHC restriction and response to superantigens. Furthermore, TCR from four liver T cell clones were sequenced. Given the low number ('x,103) of CD4 + T cells we used to establish liver cell lines, it is not surprising that all the 27 liver-derived T cell clones are identical, whereas the 22 PBMCderived T cell clones, originated from 3 x 10 s CD4 + T cells, are heterogeneous and represent at least six distinct donal populations that differ in the MHC restriction and/or superantigen responses. However, it is remarkable that none of the PBMC clones is identical to the liver-derived done, and even using a PCR oligotyping technique we did not detect the liver clonotypic TCR transcripts in the PBMC, demonstrating that this clone is in fact compartmentalized to the liver. Interestingly, the liver done provides help for polyclonal IgA production by B cells that is far more effective than that provided by the PBMC-derived clones, whereas there is no difference in the help provided for IgM and IgG production. We did not find qualitative differences in the mRNA of T cell lymphokines that could account for the difference in the help for IgA production between PBMC-and liver-derived T cells. Further studies are required both to elucidate the mechanisms responsible for this preferential help for IgA production and to investigate whether this is a general feature of intrahepatic T cells.
In the case of chronic hepatitis B, isolation of intrahepatic CD4 § T cell clones specific for either Core (23) or envelope (24) of hepatitis B virus has been reported. CD8 + T cell clones specific for the envelope of HCV have been isolated from the liver of patients with chronic hepatitis C (25). Our study shows that it is possible to establish liver-derived CD4 + T cell clones specific for the protein NS4 of HCV from patients with chronic hepatitis C. Furthermore, we have shown data very suggestive that there can be preferential sequestration into the liver of some T cell clonotypes that are not detectable in the PBMC. We cannot differentiate whether intrahepatic T cells are the cause (26) (27) (28) or the result of the liver damage, but their presence at the site where chronic infection and inflammation occur suggests they are effector cells of the immune response to HCV. Further long-term studies on biopsies and PBMC from the same patients will investigate the dynamics of intrahepatic effector T cells in the course of disease and their eventual appearance as memory cells in PBMC.
